Breakthrough cancer therapy developed at Penn receives 2nd FDA approval
May 01, 2018 at 16:43 PM EDT
The immunocellular cancer therapy can now be used to treat certain adult patients with a certain type of lymphoma. The drug was approved last year for advanced leukemia.